SEC Charges 23 Funds With Short-Selling Violations on Stock Offerings

NEW YORK (TheStreet) -- The Securities and Exchange Commission sanctioned 23 investment firms, including hedge funds D.E. Shaw and Deerfield Management and pension fund the Ontario Teachers' Pension Plan Board for short-selling violations as the agency says it works to curb a practice where investment firms participate in a company's public stock offering after short selling the stock.

Specifically, the sanctioned firms are alleged to have had violated the SEC's Rule 105 of Regulation M, which prohibits the short sale of an equity security during a restricted period -- generally five business days before a public offering -- and the purchase of that same security through the offering.

Firms charged in the SEC's enforcement action allegedly bought offered shares from an underwriter, broker, or dealer participating in a follow-on public offering after having sold short the same security during the restricted period.

The SEC said Rule 105 helps prevent short selling that can reduce offering proceeds received by companies as they seek capital from public stock investors.

The enforcement actions are being settled by 22 of the 23 firms charged, resulting in more than $14.4 million in monetary sanctions, the SEC said.

"Through this new program of streamlined investigations and resolutions of Rule 105 violations, we are sending the clear message that firms must pay the price for violations while also conserving agency resources," Andrew J. Ceresney, Co-Director of the SEC's Division of Enforcement, said in a statement.

In its complaint, the SEC alleged hedge funds as prominent as D.E. Shaw and Deerfield Management had agreed to pay monetary penalties.

If you liked this article you might like

Walgreens Is Primed to Rally, With or Without Rite Aid

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

Walgreens to Tweak Number of Rite Aid Stores It Buys to Win Regulatory Approval

Will the FTC Let Walgreens Go on a $5.2 Billion Rite Aid Shopping Spree?